Clinical Trials Sponsored by ATGen Global
Total 2504 results
-
AmgenCompletedPsoriasisUnited States, Poland, Canada, Germany, Estonia, Georgia, Hungary, Latvia
-
AmgenCompleted
-
AmgenTerminatedRelapsed and/or Refractory Multiple MyelomaUnited States, Japan, Belgium, Australia, Switzerland
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedProstate Cancer | Metastatic Castration-resistant Prostate CancerUnited States, Belgium, Austria, Singapore, Australia, Netherlands, France, Japan, Taiwan, Canada
-
AmgenCompletedCardiovascular DiseaseUnited States, Australia
-
AmgenCompletedGiant Cell Tumor of BoneAustralia, France, United States, Spain, Italy, Poland, Sweden, United Kingdom
-
AmgenActive, not recruitingNon-small Cell Lung CancerBelgium, Spain, United States, Denmark, Sweden, France, Turkey, Italy, Germany, Netherlands
-
AmgenCompletedArthritis, PsoriaticNetherlands
-
AmgenWithdrawn
-
AmgenCompletedAdvanced Solid TumorsBelgium, Canada, Australia, United States, Spain, Poland, France, Germany, Japan, United Kingdom
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompleted
-
AmgenCompletedHepatic ImpairmentUnited States
-
AmgenCompletedElectrocardiographyUnited States
-
AmgenCompletedAnti-neutrophil Cytoplasmic Antibody-associated VasculitisUnited States
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland
-
AmgenCompletedSystemic Lupus ErythematosusUnited States, Poland, Germany, France
-
AmgenCompletedGastric or Gastroesophageal CancerJapan
-
AmgenCompletedDyslipidemia | Medical Conditions to be Studied | ASCVD ManagementUnited States
-
AmgenTerminatedMixed Dyslipidemia | Primary HypercholesterolemiaChina
-
AmgenCompletedPsoriatic ArthritisSpain, Belgium, Denmark, United States, Germany, Russian Federation, Austria, United Kingdom, Canada, Italy, Switzerland
-
AmgenTerminatedDyslipidemiaBelgium, Denmark, Germany, Sweden, France, Italy, Portugal
-
AmgenCompletedHealthy VolunteersUnited States
-
AmgenCompletedRheumatoid ArthritisUnited States, Germany, Italy, Mexico, France, Canada, Hungary, Portugal, Spain, Greece, Bulgaria, Czechia, Poland, Argentina, South Africa
-
AmgenCompletedMultiple MyelomaBelgium, Austria, Czechia, Greece, Italy, France, Romania, Netherlands, Israel, Bulgaria, Norway
-
AmgenCompletedMetastatic Colorectal Cancer | Colorectal Cancer | Rectal Cancer | Colon CancerUnited States, Belgium, Canada, Italy, Germany, Spain
-
AmgenCompletedMixed Dyslipidemia | Primary HypercholesterolemiaUnited States, Canada
-
AmgenCompletedOsteoporosis, Age-RelatedUnited States, Canada
-
AmgenCompletedPostmenopausal OsteoporosisCanada, Belgium, United States, Czechia, Denmark, Poland, Hungary, Spain, Colombia, United Kingdom, Argentina
-
AmgenTerminatedAnemia | Chronic Kidney Disease | Kidney DiseaseUnited States, Belgium, Mexico, United Kingdom, Puerto Rico, Poland, Russian Federation, Latvia, Lithuania, Slovakia
-
AmgenCompletedGCT | Giant Cell Tumor of Bone
-
AmgenCompleted
-
AmgenCompletedHyperlipidemiaUnited States, Denmark, Taiwan, Korea, Republic of, Australia, Belgium, Canada, South Africa, France, Turkey
-
AmgenTerminatedMelanoma | Cancer | Colorectal Cancer | Advanced Solid Tumors | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Oncology | Tumors | Advanced Malignancy | Oncology Patients | Transitional Cell Carinoma of BladderBelgium, France, United States, Germany, Australia
-
AmgenCompletedHeterozygous Familial HypercholesterolemiaUnited States, Canada, Italy, Norway, Belgium, Turkey, Australia, New Zealand, Austria, Czechia, South Africa, Poland, Spain, Switzerland, Netherlands, Taiwan, Finland, Brazil, Portugal, Slovenia, Russian Federation, Hungary, United... and more
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompletedHealthy ParticipantsUnited States
-
AmgenCompleted
-
AmgenCompletedMigraineUnited States, Denmark, France, Spain, Portugal, Russian Federation, Greece, Switzerland
-
AmgenCompletedCarcinoma | Cancer | Head and Neck Cancer | Metastatic Cancer | Oncology | Tumors | Metastatic or Recurrent Squamous Cell Carcinoma of Head and Neck | Squamous Cell Carcinoma | Metastases
-
AmgenWithdrawnRelapsed/Refractory Multiple Myeloma
-
AmgenCompletedPostmenopausal Osteoporosis | Low Bone Mineral Density
-
AmgenCompletedCancer | Giant Cell Tumor of Bone | Giant Cell Tumors | Benign Giant Cell TumorsUnited States, Canada, Sweden, Poland, Germany, Netherlands, Australia, Italy, Austria, Spain, France, United Kingdom
-
AmgenCompletedHealthy Volunteers | Atopic Dermatitis
-
AmgenCompletedAnemia in Chronic Kidney Disease Patients Not on DialysisUnited States, Puerto Rico
-
AmgenCompletedSubjects With Hyperlipidemia, Dyslipidemia and HIV InfectionCanada, France, United States, Belgium, Italy, Spain, Switzerland, United Kingdom, South Africa, Portugal, Australia, Greece, Brazil, Romania, Poland
-
AmgenCompletedCOVID-19United States, Russian Federation, Mexico, Brazil, South Africa, Argentina, Chile, Ukraine
-
AmgenCompletedCoronary Artery Disease (CAD)Australia, Czechia, Italy, United States, Netherlands, Hungary, Germany
-
AmgenCompletedPlaque PsoriasisSpain, United States, Canada, Germany, Denmark, France, Italy, Switzerland, Austria